Interviews with Medtech Startup CEOs

Shaun Bagai, CEO of RenovoRx, on developing a targeted drug-delivery therapy platform — and his approach to commercialization by testing markets and and applying sales discipline to enrollment in clinical trials.

Justin Zenanko, CEO of SynerFuse, on developing a combined spinal fusion and neuromodulation approach — and his strategy for FDA negotiation, clinical validation, and structuring private raises to delay venture capital.

Marina Pavlovic Rivas, CEO of Eli Health, on developing real-time hormone monitoring technology — and her approach to design decisions, beta testing, and positioning for cash-pay, consumer adoption.

Greg Walters, CEO of Excision Medical, on developing RF-enabled leaflet modification technology for TAVR — and his approach to prototyping, first-in-human risk, and what acquirers actually look for in pre-revenue medtech.

Jaeson Bang, Founder & CEO of Future Cardia, shares how developing a subcutaneous heart-failure monitoring platform came from challenging assumptions — and why delaying VC capital can preserve leverage and speed.

Urologist-turned-founder Dr. Adam Kadlec shares how he built Rivermark and FloStent — a reversible, workflow-friendly device for BPH — by designing for real practice patterns and uncovering what drives trial enrollment.